Skip to main content

Internet Explorer 11 (IE11) is not supported. For the best experience please open using Chrome, Firefox, Safari or MS Edge

MHC logo CAPSULE
Medical Devices Pharma Digital Health Cosmetics Food Chemicals
Menu
  • Sectors
  • Medical Devices
  • Pharma
  • Digital Health
  • Cosmetics
  • Food
  • Chemicals
  • Practice Areas
  • Artificial Intelligence
  • Commercial
  • Competition
  • Construction
  • Corporate Governance
  • Cyber Security
  • Data Privacy
  • ESG
  • Healthcare Litigation
  • Intellectual Property
  • Product Liability
  • Real Estate
  • Regulatory
  • Tax
  • Transactional
  • Other
  • Latest
  • People
Search Capsule
Site Search

L a t e s t

  • All
  • News
  • Events
  • Insights
  • Podcasts
  • Videos
  • Clear ✕
  • Clear ✕

19/12/25

Agreement Reached on EU Pharma Package

Insights Pharma

19/12/25

Featured in the IBA Healthcare and Life Sciences Law Committee eBulletin

Insights Regulatory

17/12/25

EU Commission Proposes Reform of the Medical and In Vitro Device Regulations

Insights Medical Devices

28/11/25

Non-Alcoholic Gin Can’t be Labelled as ‘Gin’

Insights Food

27/11/25

Revised EU Manual on Device Classification

Insights Medical Devices

01/10/25

Renegotiation of the IPHA Framework Agreement Update

Insights Pharma

01/10/25

CJEU Decision on Classification as a ‘Medical Device’ or a ‘Medicinal Product’

Insights Medical Devices

01/10/25

TPO Ban in the EU

Insights Cosmetics

01/10/25

Consultation to Simplify EU Rules for Medical Devices

Insights Medical Devices

24/09/25

Anna Lundy Appointed Of Counsel

News Medical Devices

23/09/25

Marketing Authorisations

Insights Pharma

23/09/25

Pricing & Reimbursement in Ireland

Insights Pharma

10/07/25

Product & Consumer Protection Mid-year Review 2025

Insights Regulatory

10/07/25

Digital Health Mid-year Review 2025

Insights Digital Health

10/07/25

AI Liability

Insights Artificial Intelligence

10/07/25

Defining Borders in Borderless Care

Insights Digital Health
Loading
MHC logo CAPSULE
  • Sectors
  • Medical Devices
  • Pharma
  • Digital Health
  • Cosmetics
  • Food
  • Chemicals
  • Other
  • Latest
  • People
  • Practice Areas
  • Artificial Intelligence
  • Commercial
  • Competition
  • Construction
  • Corporate Governance
  • Cyber Security
  • Data Privacy
  • ESG
  • Healthcare Litigation
  • Intellectual Property
  • Product Liability
  • Real Estate
  • Regulatory
  • Tax
  • Transactional
  • Accolades
  • Client Choice
  • Lexology Index
Privacy Policy | Cookie Policy | Disclaimer | Modern Slavery Statement | Accessibility | ©2025 Mason Hayes & Curran LLP